Cutting Edge: Treating Depression Safely and Successfully

We are living through a transformative time in mental health research. There is overwhelming demand for new and safe ways of addressing various states of depression. Dr. Nolan Williams and Stanford University are leaders in cutting-edge research that is generating worldwide attention.

Attend this fascinating program to learn what is currently being done in research settings as well as the breakthrough technology that is in the process of being developed so it can be in every medical setting and available to people who need treatment and support.

At Stanford, Dr. William’s Brain Stimulation Lab developed a now-FDA-cleared, personalized, accelerated neuromodulation treatment known as Stanford Accelerated Intelligent Neuromodulation Therapy (SAINT). The innovative SAINT approach is having a very positive impact on the treatment of severe depression. In a double-blind, randomized controlled trial, high doses of magnetic brain stimulation, given on an accelerated timeline and individually targeted, brought rapid remission to 79 percent of trial participants with severe depression compared to people in the sham treatment arm, where 13 percent of the people entered remission.

The SAINT approach provides a novel form of rapid-acting, non-invasive, individually targeted neuromodulation that uses electromagnetic pulses to relieve symptoms of treatment-resistant depression. For the first time, advanced tools for processing MRI-based images of the brain are used to steer a specialized, high-dose pattern of magnetic pulses to induce neurons to fire. The stimulation modifies activity in brain networks related to depression, changing the brain’s circuitry to more effectively treat major depression.

SAINT has additionally been studied in open-label studies. Overall, the therapy has been shown to be effective in the treatment of major depressive disorder, with approximately 80–90 percent of patients achieving remission of depression symptoms following the five-day treatment protocol.

Dr. Williams has been interviewed extensively by the media and has appeared on programs such as "CBS News Sunday Morning with Jane Pauley," "The Today show" on NBC, and on NPR, discussing the benefits of SAINT for relieving symptoms of treatment-resistant depression.  

SPEAKERS

Dr. Nolan Williams

Assistant Professor, Department of Psychiatry and Behavioral Sciences; Director of the Stanford Brain Stimulation Lab, Stanford University

Adrea Brier

CNHP, CLC, Integrative Cancer Consultant and Advocate—Moderator

In response to the COVID-19 pandemic, we are currently hosting all of our live programming via YouTube live stream. This program was recorded via video conference on November 8th, 2022 by the Commonwealth Club of California.

Learn more about your ad choices. Visit megaphone.fm/adchoices